Net Income (Loss) Attributable to Parent in USD of Biostax Corp. from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biostax Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2012 to Q2 2024.
  • Biostax Corp. Net Income (Loss) Attributable to Parent for the quarter ending 30 Jun 2024 was -$428K, a 15.1% increase year-over-year.
  • Biostax Corp. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Jun 2024 was -$2.22M, a 39.8% increase year-over-year.
  • Biostax Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$2.36M, a 33.2% increase from 2022.
  • Biostax Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.54M, a 199% decline from 2021.
  • Biostax Corp. annual Net Income (Loss) Attributable to Parent for 2021 was $3.59M, a 126% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Biostax Corp. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.22M -$428K +$76.3K +15.1% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 -$2.3M -$353K +$63.5K +15.3% 01 Jan 2024 31 Mar 2024 10-Q/A 19 Aug 2024
Q4 2023 -$2.36M -$1.05M -$775K -278% 01 Oct 2023 31 Dec 2023 10-K/A 05 Jul 2024
Q3 2023 -$1.59M -$389K +$2.1M +84.4% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 -$3.69M -$504K -$2.3M -128% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$1.4M -$416K +$2.14M +83.7% 01 Jan 2023 31 Mar 2023 10-Q/A 19 Aug 2024
Q4 2022 -$3.54M -$279K -$74.3K -36.3% 01 Oct 2022 31 Dec 2022 10-K/A 05 Jul 2024
Q3 2022 -$3.46M -$2.49M -$5.61M -180% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $2.14M $1.79M +$1.91M 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 $239K -$2.56M -$3.35M -423% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $3.59M -$205K +$705K +77.5% 01 Oct 2021 31 Dec 2021 10-K 10 Apr 2023
Q3 2021 $2.88M $3.11M -$981K -24% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $3.86M -$113K +$691K +86% 01 Apr 2021 30 Jun 2021 10-Q 24 Aug 2022
Q1 2021 $3.17M $790K +$1.58M 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $1.59M -$909K 01 Oct 2020 31 Dec 2020 10-K 18 Mar 2022
Q3 2020 $4.09M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$804K 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$793K 01 Jan 2020 31 Mar 2020 10-Q 24 May 2021
Q4 2017 -$7.93M -$3.78M +$1.41M +27.2% 01 Oct 2017 31 Dec 2017 10-K 02 Apr 2018
Q3 2017 -$9.35M -$1.6M +$2.34M +59.4% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 -$11.7M $149K +$4.19M 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 -$15.9M -$2.71M +$3.94M +59.3% 01 Jan 2017 31 Mar 2017 10-Q 12 May 2017
Q4 2016 -$19.8M -$5.19M +$2.24M +30.1% 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2018
Q3 2016 -$22.1M -$3.94M +$81.4K +2.02% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$22.1M -$4.04M -$1.45M -55.9% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$20.7M -$6.65M -$3.74M -129% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$16.9M -$7.43M +$7.06M +48.7% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$24M -$4.03M +$7.18M +64.1% 01 Jul 2015 30 Sep 2015 10-Q 15 Nov 2016
Q2 2015 -$31.2M -$2.59M +$4M +60.7% 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$35.2M -$2.91M +$14.8M +83.6% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$49.9M -$14.5M +$32.3M +69% 01 Oct 2014 31 Dec 2014 10-K/A 16 May 2016
Q3 2014 -$82.2M -$11.2M +$8.74M +43.8% 01 Jul 2014 30 Sep 2014 10-Q/A 22 Dec 2015
Q2 2014 -$90.9M -$6.59M +$18.1M +73.3% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$109M -$17.7M -$2.98M -20.3% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 -$106M -$46.7M +$128M +73.2% 01 Oct 2013 31 Dec 2013 10-K 31 Mar 2015
Q3 2013 -$234M -$19.9M -$19.6M -6175% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 -$214M -$24.7M -$24.7M -144091% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$190M -$14.7M -$14.7M 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$175M -$175M 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 -$318K 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$17.1K 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013
Q1 2012 $597* 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013

Biostax Corp. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.36M +$1.17M +33.2% 01 Jan 2023 31 Dec 2023 10-K/A 05 Jul 2024
2022 -$3.54M -$7.12M -199% 01 Jan 2022 31 Dec 2022 10-K/A 05 Jul 2024
2021 $3.59M +$2M +126% 01 Jan 2021 31 Dec 2021 10-K 10 Apr 2023
2020 $1.59M 01 Jan 2020 31 Dec 2020 10-K 18 Mar 2022
2017 -$7.93M +$11.9M +60% 01 Jan 2017 31 Dec 2017 10-K 02 Apr 2018
2016 -$19.8M -$2.87M -16.9% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2015 -$16.9M +$33M +66.1% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$49.9M +$56.1M +52.9% 01 Jan 2014 31 Dec 2014 10-K/A 16 May 2016
2013 -$106M +$68.9M +39.4% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015
2012 -$175M 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.